- Campaigners are calling on the UK government to urgently intervene over the cost of a drug that could extend the lives of thousands of children but which manufacturers have set at £105,000 per patient per year, a price the NHS cannot afford. https://www.theguardian.com/science/2019/feb/03/nhs-cystic-fibrosis-drug-orkambi-vertex? 155 comments worldnews
Linking pages
- Labour pledges to break patents and offer latest drugs on NHS | Labour conference 2019 | The Guardian https://www.theguardian.com/politics/2019/sep/24/labour-pledges-to-break-patents-and-offer-latest-drugs-on-nhs 147 comments
- Outrage as cystic fibrosis drug firm posts big profit | Cystic fibrosis | The Guardian https://www.theguardian.com/society/2019/feb/10/vertex-revenue-hike-orkambi-drug-nhs 131 comments
- £14m pay deal for boss of 'unaffordable' cystic fibrosis drug | Pharmaceuticals industry | The Guardian https://www.theguardian.com/business/2019/may/09/14m-pay-deal-for-boss-of-unaffordable-cystic-fibrosis-drug 3 comments
Linked pages
Related searches:
Search whole site: site:www.theguardian.com
Search title: Calls for action on patients denied £100,000 cystic fibrosis drug | Drugs | The Guardian
See how to search.